|
Briefing
|
- Organs-on-Chips FDA Study – U.S. Food and Drug Administration (FDA) signed multi-year agreement with biotechnology company Emulate to use its organs-on-chips technology to assess effects and risks of chemicals found in foods, cosmetics, and dietary supplements on humans
- How It Works – Each organ-on-a-chip contains tiny channels mimicking flow of blood or air in body and lined with living human cells, such as liver or lung cells
- Start with Liver-On-A-Chip – Research will start with liver-on-a-chip but can extend to other models, such as kidney, lung and intestine versions
- Multiple Organs-On-Chips – Emulate says different organs-on-a-chip can be connected together to resemble how chemicals can affect multiple organs in body
|
|
Accelerator
|
|
|
Sector
|
Healthcare/Health Sciences
|
|
Organization
|
Emulate Inc., U.S. Food and Drug Administration
|
|
Source
|
-
Fitzpatrick, S., "‘Organs-on-Chips’ technology: FDA testing groundbreaking science",
-
Miller, S., "'Organ Chip' project to test how chemicals affect the body",
-
"Organs-on Chips technology,"
-
"31 October 2016 – Intel Capital invests $38m in 12 startups, MIT creates an Incubator called Engine and Much More,"
-
"Emulate Inc.,"
-
AcceleratingBiz analysis
|
|
Original Publication Date
|
April 18, 2017
|
